Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Amicus Therapeutics Current Ratio 2007-2019 | FOLD

Amicus Therapeutics current ratio from 2007 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Amicus Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.64B $0.09B 7.09
2019-03-31 $0.48B $0.07B 7.33
2018-12-31 $0.55B $0.09B 6.40
2018-09-30 $0.60B $0.07B 9.12
2018-06-30 $0.58B $0.05B 10.88
2018-03-31 $0.59B $0.14B 4.21
2017-12-31 $0.39B $0.07B 5.60
2017-09-30 $0.43B $0.07B 6.32
2017-06-30 $0.24B $0.10B 2.39
2017-03-31 $0.30B $0.11B 2.70
2016-12-31 $0.34B $0.11B 3.07
2016-09-30 $0.22B $0.09B 2.59
2016-06-30 $0.22B $0.08B 2.71
2016-03-31 $0.17B $0.06B 2.62
2015-12-31 $0.22B $0.07B 2.94
2015-09-30 $0.24B $0.04B 6.69
2015-06-30 $0.37B $0.02B 21.60
2015-03-31 $0.15B $0.02B 7.20
2014-12-31 $0.16B $0.02B 7.66
2014-09-30 $0.09B $0.01B 6.31
2014-06-30 $0.08B $0.01B 7.11
2014-03-31 $0.07B $0.01B 7.84
2013-12-31 $0.09B $0.01B 8.44
2013-09-30 $0.06B $0.01B 7.48
2013-06-30 $0.08B $0.01B 7.74
2013-03-31 $0.09B $0.01B 10.98
2012-12-31 $0.11B $0.01B 11.32
2012-09-30 $0.11B $0.01B 11.33
2012-06-30 $0.11B $0.02B 5.93
2012-03-31 $0.12B $0.02B 6.49
2011-12-31 $0.07B $0.02B 3.46
2011-09-30 $0.08B $0.02B 4.10
2011-06-30 $0.09B $0.02B 5.22
2011-03-31 $0.10B $0.02B 6.01
2010-12-31 $0.11B $0.02B 6.76
2010-09-30 $0.06B $0.01B 7.42
2010-06-30 $0.07B $0.01B 9.96
2010-03-31 $0.08B $0.01B 9.50
2009-12-31 $0.08B $0.01B 7.19
2009-09-30 $0.09B $0.02B 5.48
2009-06-30 $0.10B $0.02B 6.77
2009-03-31 $0.11B $0.01B 8.84
2008-12-31 $0.12B $0.01B 9.24
2008-09-30 $0.14B $0.02B 9.26
2008-06-30 $0.15B $0.02B 9.58
2008-03-31 $0.16B $0.02B 10.51
2007-12-31 $0.16B $0.02B 10.32
2007-09-30 $0.12B $0.01B 12.61
2007-06-30 $0.13B $0.01B 18.26
2007-03-31 $0.00B 0.00
2006-09-30 $0.00B 0.00
2006-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.069B $0.091B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.571B 13.85
Gilead Sciences (GILD) United States $82.206B 10.10
CSL (CSLLY) Australia $77.954B 0.00
Celgene (CELG) United States $72.965B 11.29
Illumina (ILMN) United States $45.488B 53.44
Vertex Pharmaceuticals (VRTX) United States $45.297B 48.95
Biogen (BIIB) United States $40.589B 7.21
Regeneron Pharmaceuticals (REGN) United States $32.970B 14.97
Alexion Pharmaceuticals (ALXN) United States $22.066B 11.63
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.379B 0.00
Incyte (INCY) United States $16.724B 49.22
Seattle Genetics (SGEN) United States $14.134B 0.00
Genmab (GNMSF) Denmark $13.038B 73.13
Exact Sciences (EXAS) United States $12.491B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.410B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.175B 54.54
Alnylam Pharmaceuticals (ALNY) United States $9.428B 0.00
Galapagos (GLPG) Belgium $8.608B 0.00
Bio-Techne Corp (TECH) United States $7.588B 52.42
QIAGEN (QGEN) Netherlands $6.425B 21.10
Sarepta Therapeutics (SRPT) United States $6.376B 0.00
BeiGene (BGNE) Cayman Islands $6.281B 0.00
Guardant Health (GH) United States $6.068B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.772B 0.00
Amarin (AMRN) Ireland $5.762B 0.00
Reata Pharmaceuticals (RETA) United States $5.567B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.109B 12.99
Exelixis (EXEL) United States $4.974B 12.93
Bluebird Bio (BLUE) United States $4.948B 0.00
Moderna (MRNA) United States $4.890B 0.00
China Biologic Products (CBPO) China $4.547B 28.38
Medicines (MDCO) United States $4.522B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.392B 0.00
Ascendis Pharma (ASND) Denmark $4.167B 0.00
Repligen (RGEN) United States $4.044B 78.48
Spark Therapeutics (ONCE) United States $3.850B 0.00
Blueprint Medicines (BPMC) United States $3.691B 0.00
MorphoSys AG (MOR) Germany $3.507B 0.00
Mirati Therapeutics (MRTX) United States $3.001B 0.00
Immunomedics (IMMU) United States $2.964B 0.00
Alkermes (ALKS) Ireland $2.852B 0.00
Emergent Biosolutions (EBS) United States $2.833B 42.57
Genmab (GMAB) Denmark $2.710B 0.00
MyoKardia (MYOK) United States $2.665B 0.00
Genomic Health (GHDX) United States $2.616B 49.06
Ultragenyx Pharmaceutical (RARE) United States $2.464B 0.00
Arena Pharmaceuticals (ARNA) United States $2.432B 5.23
Myriad Genetics (MYGN) United States $2.274B 23.70
Halozyme Therapeutics (HALO) United States $2.232B 0.00
Acceleron Pharma (XLRN) United States $2.221B 0.00
RA PHARMCTL INC (RARX) United States $2.174B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.128B 0.00
NeoGenomics (NEO) United States $2.103B 112.50
CRISPR Therapeutics AG (CRSP) Switzerland $2.072B 0.00
Ligand Pharmaceuticals (LGND) United States $2.014B 25.46
Cambrex (CBM) United States $2.003B 25.32
Zai Lab (ZLAB) China $1.978B 0.00
Akcea Therapeutics (AKCA) United States $1.682B 0.00
UniQure (QURE) Netherlands $1.626B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.586B 0.00
Insmed (INSM) United States $1.554B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.460B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.421B 0.00
REGENXBIO (RGNX) United States $1.389B 0.00
Denali Therapeutics (DNLI) United States $1.380B 0.00
Coherus BioSciences (CHRS) United States $1.344B 0.00
Zymeworks (ZYME) Canada $1.164B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.152B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.120B 0.00
Innoviva (INVA) United States $1.097B 3.17
AnaptysBio (ANAB) United States $1.002B 0.00
Alector (ALEC) United States $0.990B 0.00
Editas Medicine (EDIT) United States $0.977B 0.00
Sangamo Therapeutics (SGMO) United States $0.962B 0.00
Epizyme (EPZM) United States $0.941B 0.00
ANI Pharmaceuticals (ANIP) United States $0.902B 15.07
Fate Therapeutics (FATE) United States $0.891B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Zealand Pharma (ZEAL) Denmark $0.851B 9.55
Achillion Pharmaceuticals (ACHN) United States $0.851B 0.00
Anika Therapeutics (ANIK) United States $0.798B 28.23
Athenex (ATNX) United States $0.791B 0.00
Codexis (CDXS) United States $0.786B 0.00
Twist Bioscience (TWST) United States $0.770B 0.00
Cara Therapeutics (CARA) United States $0.766B 0.00
Principia Biopharma (PRNB) United States $0.731B 378.13
Vanda Pharmaceuticals (VNDA) United States $0.724B 26.14
Pharming Group (PHGUF) Netherlands $0.724B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
WAVE Life Sciences (WVE) Singapore $0.705B 0.00
Vericel (VCEL) United States $0.682B 0.00
Revance Therapeutics (RVNC) United States $0.669B 0.00
Cytokineticsorporated (CYTK) United States $0.644B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.641B 0.00
Mesoblast (MESO) Australia $0.597B 0.00
Heska (HSKA) United States $0.592B 76.70
GENFIT S.A (GNFT) France $0.564B 0.00
MiMedx (MDXG) United States $0.555B 0.00
Intellia Therapeutics (NTLA) United States $0.534B 0.00
Arvinas (ARVN) United States $0.519B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.494B 0.00
PHARMA MAR SA (PHMMF) Spain $0.494B 0.00
Retrophin (RTRX) United States $0.483B 0.00
UROGEN PHARMA (URGN) United States $0.466B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.462B 0.00
BioDelivery Sciences (BDSI) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Intra-Cellular Therapies (ITCI) United States $0.457B 0.00
DBV Technologies S.A (DBVT) France $0.457B 0.00
Adverum Biotechnologies (ADVM) United States $0.446B 0.00
Cellectis S.A (CLLS) France $0.431B 0.00
Bellus Health (BLU) Canada $0.399B 0.00
Stemline Therapeutics (STML) United States $0.397B 0.00
Arcus Biosciences (RCUS) United States $0.387B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.380B 0.00
Kadmon Holdings (KDMN) United States $0.377B 0.00
Merus (MRUS) Netherlands $0.373B 0.00
Agenus (AGEN) United States $0.360B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.340B 0.00
Precision BioSciences (DTIL) United States $0.326B 0.00
AC Immune SA (ACIU) Switzerland $0.324B 23.95
Kindred Biosciences (KIN) United States $0.312B 0.00
Prothena (PRTA) Ireland $0.311B 0.00
CytomX Therapeutics (CTMX) United States $0.305B 0.00
Protagonist Therapeutics (PTGX) United States $0.305B 0.00
Avid Bioservices (CDMO) United States $0.292B 0.00
Syros Pharmaceuticals (SYRS) United States $0.286B 0.00
Cellular Biomedicine (CBMG) United States $0.285B 0.00
Starpharma Holdings (SPHRY) Australia $0.284B 0.00
Gritstone Oncology (GRTS) United States $0.279B 0.00
Theratechnologies (THTX) Canada $0.278B 0.00
PDL BioPharma (PDLI) United States $0.271B 6.97
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.270B 0.00
Scholar Rock Holding (SRRK) United States $0.270B 0.00
Geron (GERN) United States $0.269B 0.00
Dynavax Technologies (DVAX) United States $0.266B 0.00
ADMA Biologics Inc (ADMA) United States $0.266B 0.00
Puma Biotechnology (PBYI) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.247B 368.33
MannKind (MNKD) United States $0.243B 0.00
Seres Therapeutics (MCRB) United States $0.242B 0.00
OSMOTICA PHARM (OSMT) United States $0.234B 0.00
Sutro Biopharma (STRO) United States $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.227B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.226B 0.00
Albireo Pharma (ALBO) United States $0.223B 0.00
Inovio Pharmaceuticals (INO) United States $0.223B 0.00
Exicure (XCUR) United States $0.214B 0.00
Kamada (KMDA) Israel $0.208B 7.94
Athersys (ATHX) United States $0.205B 0.00
Sorrento Therapeutics (SRNE) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.200B 0.00
Compugen (CGEN) Israel $0.200B 0.00
ChromaDex (CDXC) United States $0.198B 0.00
Clovis Oncology (CLVS) United States $0.183B 0.00
Affimed (AFMD) Germany $0.180B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.178B 0.00
Dyadic (DYAI) United States $0.176B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Prometic Life Sciences (PFSCF) Canada $0.174B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.172B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cue Biopharma (CUE) United States $0.161B 0.00
XOMA (XOMA) United States $0.160B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.156B 0.00
Enzo Biochem (ENZ) United States $0.154B 0.00
Arsanis (XFOR) United States $0.152B 0.00
Senesco Technologies (ELOX) United States $0.151B 0.00
Cerecor (CERC) United States $0.150B 0.00
Five Prime Therapeutics (FPRX) United States $0.147B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.146B 0.00
Alcobra (ARCT) United States $0.139B 0.00
Northwest Biotherapeutics (NWBO) United States $0.135B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.120B 0.00
Menlo Therapeutics (MNLO) United States $0.120B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Acorda Therapeutics (ACOR) United States $0.118B 0.00
PHASEBIO PHARMA (PHAS) United States $0.115B 0.00
NantKwest (NK) United States $0.114B 0.00
Strongbridge Biopharma (SBBP) United States $0.108B 4.42
Novavax (NVAX) United States $0.107B 0.00
Abeona Therapeutics (ABEO) United States $0.107B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.105B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.101B 0.00
Aptinyx (APTX) United States $0.101B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
OvaScience (MLND) United States $0.095B 0.00
VBI Vaccines (VBIV) United States $0.094B 0.00
Celyad SA (CYAD) Belgium $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Fortress Biotech (FBIO) United States $0.088B 0.00
Liquidia Technologies (LQDA) United States $0.086B 0.00
Trevena (TRVN) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.084B 0.00
Aduro Biotech (ADRO) United States $0.081B 0.00
Mersana Therapeutics (MRSN) United States $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Idera Pharmaceuticals (IDRA) United States $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.072B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Curis (CRIS) United States $0.071B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Selecta Biosciences (SELB) United States $0.064B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.062B 22.53
VistaGen Therapeutics (VTGN) United States $0.059B 0.00
AquaBounty Technologies (AQB) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Pluristem Therapeutics (PSTI) Israel $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.054B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.054B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
NewLink Genetics (NLNK) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.046B 0.00
Unum Therapeutics (UMRX) United States $0.046B 0.00
VIVUS (VVUS) United States $0.046B 0.00
Evogene (EVGN) Israel $0.043B 0.00
Ophthotech (ISEE) United States $0.040B 0.00
Stellar Biotechnologies (EDSA) Canada $0.039B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.038B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
Proteostasis Therapeutics (PTI) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Neuralstem (CUR) United States $0.003B 0.00